More vaccines enter clinical trials
2021-04-22 00:00
China has about a dozen COVID vaccines that have entered clinical trials, in addition to the four vaccines already on the market, Shao Yiming, chief expert at the Chinese Center for Disease Control and Prevention, told a news briefing on Wednesday.He said an attenuated influenza virus vector vaccine has completed early and midstage clinical trials and has demonstrated excellent safety and ability to cause an immune response. Research on mRNA and DNAbased vaccines has also shown promise in preclinical studies and has entered midstage clinical trials.The government laid out five technical routes to develop vaccines early in the COVID outbreak, with three inactivated vaccines and one adenovirus vector vaccine already marketed and a recombinant protein vaccine approved for emergency use.                                                                                                                                                                                                                                                                           !CDATA            function shareweixin              var ua  navigator.userAgent.toLowerCase              ifiphoneipadipod.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyiosschemeencodeIos                            else ifandroid.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyandroidschemeencodeAndroid                            else                window.openwww.chinadaily.com.cnmobiledaily.html